Peptide Legal Status in 2026: What's Allowed and What's Not

The legal status of research peptides in the United States is nuanced. The answer depends on classification, intended use, and how products are marketed. This guide summarizes the current regulatory framework as of March 2026.

The Key Distinction: Intended Use

Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), a product's legal classification depends primarily on its intended use. A peptide marketed for human consumption, therapeutic purposes, or disease treatment is classified as a "drug" under 21 U.S.C. § 321(g)(1) and requires FDA approval. A peptide sold as a chemical reference material for in-vitro laboratory research occupies a different regulatory space — it is not a drug because it is not intended for any use in humans or animals.

Category 2 Peptides

In September 2023, the FDA placed 17 peptides on its Category 2 list under the interim policy for bulk drug substances. This prohibits compounding pharmacies from producing these peptides for patient use. Category 2 peptides include BPC-157, TB-500, AOD-9604, Ipamorelin, CJC-1295, and others. This restriction applies to compounding pharmacies — it does not, on its face, prohibit the sale of these compounds as research chemical reference materials labeled for in-vitro use only.

GLP-1 Agonist Restrictions

In February 2025, the FDA declared the semaglutide shortage resolved, ending the compounding exception that had allowed pharmacies to produce generic semaglutide. The ITC issued a General Exclusion Order on imported tirzepatide products. These actions target compounding and importation of these compounds as drugs — not the sale of research-grade reference materials.

What's Legal to Purchase

State Variations

Some states impose additional requirements. New York (2024) prohibited sale of muscle-building and weight-loss supplements to minors. Florida requires registration for drug manufacturers and wholesale distributors handling peptides. It is the buyer's responsibility to comply with all state and local regulations in their jurisdiction.

How Pepta Labs Maintains Compliance

Every product is labeled "Research Use Only." We make zero therapeutic claims. All buyers certify research-only use at checkout. Third-party COAs verify purity independently. See our complete Compliance Policy and Terms of Service for our full legal framework.